• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病认知障碍的分期:快速痴呆评定量表的有效性。

Staging of cognitive impairment in Parkinson's disease: validity of Quick Dementia Rating System.

机构信息

Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.

Department of Neurosciences, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Disabil Rehabil. 2022 Jan;44(1):44-51. doi: 10.1080/09638288.2020.1755728. Epub 2020 May 6.

DOI:10.1080/09638288.2020.1755728
PMID:32374182
Abstract

PURPOSE

This study aimed to investigate the ability of the Quick Dementia Rating System (QDRS) to discriminate patients with PD who have mild cognitive impairment from those without cognitive impairment and those with dementia.

METHOD

A total of 105 patients with PD were classified as without cognitive impairment ( = 32), with mild cognitive impairment ( = 23), and PDD ( = 50), according to their score on clinical dementia rating. Multivariate regression analysis was performed considering age, education, and disease severity as covariates and mild cognitive impairment or dementia as outcome variables. Receiver operating characteristic curve analysis was carried out to derive the optimal cut-off points.

RESULTS

The cut-off point >2.5 (sensitivity = 86.96%, area under curve (AUC) = 0.88) was obtained for discriminating patients with mild cognitive impairment from those without cognitive impairment based on the total score of QDRS. The cut-off point >5 (sensitivity = 84%, AUC = 0.84) was derived for discriminating mild cognitive impairment from dementia based on the total score of QDRS.

CONCLUSIONS

The results of this study showed a good discriminative validity of the QDRS for discriminating mild cognitive impairment from no cognitive impairment and dementia in patients with PD.IMPLICATIONS FOR REHABILITATIONThe Quick Dementia Rating System has a good discriminative validity for diagnosing mild cognitive impairment from normal cognitive function in Parkinson's disease.The Quick Dementia Rating System has a good discriminative validity for diagnosing mild cognitive impairment from dementia in Parkinson's disease.The Quick Dementia Rating System could be suggested as a routine rapid cognitive screening tool for patients with Parkinson's disease.

摘要

目的

本研究旨在探讨快速痴呆评定量表(QDRS)区分伴有轻度认知障碍、无认知障碍和痴呆的帕金森病(PD)患者的能力。

方法

根据临床痴呆评定量表评分,将 105 例 PD 患者分为无认知障碍( = 32)、轻度认知障碍( = 23)和 PD 痴呆( = 50)。考虑年龄、教育程度和疾病严重程度作为协变量,将轻度认知障碍或痴呆作为因变量进行多元回归分析。进行受试者工作特征曲线分析以获得最佳截断值。

结果

根据 QDRS 总分,区分无认知障碍患者与轻度认知障碍患者的最佳截断值>2.5(敏感性=86.96%,曲线下面积(AUC)=0.88)。根据 QDRS 总分,区分轻度认知障碍与痴呆的最佳截断值>5(敏感性=84%,AUC=0.84)。

结论

本研究结果表明,QDRS 对区分 PD 患者的轻度认知障碍与无认知障碍和痴呆具有良好的判别效度。

对康复的启示

快速痴呆评定量表对诊断帕金森病患者的轻度认知障碍与正常认知功能具有良好的判别效度。快速痴呆评定量表对诊断帕金森病患者的轻度认知障碍与痴呆具有良好的判别效度。快速痴呆评定量表可作为帕金森病患者的常规快速认知筛查工具。

相似文献

1
Staging of cognitive impairment in Parkinson's disease: validity of Quick Dementia Rating System.帕金森病认知障碍的分期:快速痴呆评定量表的有效性。
Disabil Rehabil. 2022 Jan;44(1):44-51. doi: 10.1080/09638288.2020.1755728. Epub 2020 May 6.
2
Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.帕金森病认知评定量表在伊朗特发性帕金森病患者中的信度、效度和诊断准确性。
Disabil Rehabil. 2022 May;44(10):2091-2098. doi: 10.1080/09638288.2020.1813337. Epub 2020 Sep 14.
3
Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.帕金森病可能轻度认知障碍的诊断:SCOPA-Cog 的有效性。
Parkinsonism Relat Disord. 2013 Dec;19(12):1160-3. doi: 10.1016/j.parkreldis.2013.08.008. Epub 2013 Aug 22.
4
A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.一种用于帕金森病痴呆日常生活活动功能的高效筛查工具。
J Clin Exp Neuropsychol. 2020 Oct;42(8):867-879. doi: 10.1080/13803395.2020.1825634. Epub 2020 Oct 12.
5
Using a patient-reported outcome to improve detection of cognitive impairment and dementia: The patient version of the Quick Dementia Rating System (QDRS).使用患者报告的结果来提高认知障碍和痴呆的检测:快速痴呆评定系统(QDRS)患者版。
PLoS One. 2020 Oct 15;15(10):e0240422. doi: 10.1371/journal.pone.0240422. eCollection 2020.
6
Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.认知特征及常规认知测试在老年帕金森病、帕金森病痴呆、阿尔茨海默病及认知正常个体中的最佳截断值。
Psychogeriatrics. 2020 Jan;20(1):20-27. doi: 10.1111/psyg.12451. Epub 2019 Mar 25.
7
Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.帕金森病认知评定量表:用于轻度认知障碍的心理测量学。
Mov Disord. 2013 Sep;28(10):1376-83. doi: 10.1002/mds.25568. Epub 2013 Jul 19.
8
Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.帕金森病的认知筛查:帕金森神经心理痴呆评估(PANDA)与其他3种简短量表的比较
Rev Neurol (Paris). 2016 Feb;172(2):138-45. doi: 10.1016/j.neurol.2015.08.004. Epub 2015 Oct 20.
9
Validation of the Informant Quick Dementia Rating System (QDRS) among Older Adults in Singapore.验证信息者快速痴呆评定量表(QDRS)在新加坡老年人中的适用性。
J Alzheimers Dis. 2022;89(4):1323-1330. doi: 10.3233/JAD-220520.
10
Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.蒙特利尔认知评估量表、简易精神状态检查和 SCOPA-Cog 在非痴呆帕金森病患者中的变化反应性。
Dement Geriatr Cogn Disord. 2019;47(4-6):187-197. doi: 10.1159/000496454. Epub 2019 Jul 17.

引用本文的文献

1
Reliability and validity analysis of the Chinese version of the Quick Dementia Rating System (QDRS).简易痴呆评定系统中文版(QDRS)的信效度分析
BMC Geriatr. 2025 Jul 2;25(1):455. doi: 10.1186/s12877-025-06112-3.
2
Performance of study partner reports in a non-demented at-risk sample.研究伙伴报告在非痴呆高危样本中的表现。
Alzheimers Dement. 2025 Feb;21(2):e14470. doi: 10.1002/alz.14470. Epub 2024 Dec 23.